Synthetic resins or natural rubbers -- part of the class 520 ser – Synthetic resins – Processes of preparing a desired or intentional composition...
Reexamination Certificate
2005-08-23
2005-08-23
Szekely, Peter (Department: 1714)
Synthetic resins or natural rubbers -- part of the class 520 ser
Synthetic resins
Processes of preparing a desired or intentional composition...
C424S422000, C424S423000, C424S426000, C424S499000, C514S021800, C514S801000, C523S309000
Reexamination Certificate
active
06933326
ABSTRACT:
A method of processing an acellular tissue matrix to give a particulate acellular tissue matrix includes: cutting sheets of dry acellular tissue matrix into strips; cryofracturing the dry acellular tissue matrix strips at cryogenic temperatures; separating the resulting particles by size at cryogenic temperatures; and freeze drying the fraction of particles desired size to remove any moisture that may have been absorbed to give a dry particulate acellular tissue matrix. Rehydration of the dry particulate acellular tissue matrix may take place just prior to use. The particulate acellular tissue may be applied to a recipient site, by way of injection, spraying, layering, packing, in-casing or combinations thereof. The particulate acellular tissue may further include growth and stimulating agents selected from epidermal growth factor, fibroblast growth factor, nerve growth factor, keratinocyte growth factor, platelet derived growth factor, vasoactive intestinal peptide, stem cell factor, bone morphogetic proteins, chondrocyte growth factor and combinations thereof. Other pharmaceutically active compounds may be combined with the rehydrated particulate material including: analgesic drugs; hemostatic drugs; antibiotic drugs; local anesthetics and the like to enhance the acceptance of the implanted particulate material. The particulate material product may also be combined with stem cells selected from mesenchymal stem cells, epidermal stem cells, cartilage stem cells, hematopoietic stem cells and combinations thereof.
REFERENCES:
patent: 4347841 (1982-09-01), Benyo et al.
patent: 4350629 (1982-09-01), Yannas et al.
patent: 4352883 (1982-10-01), Lim
patent: 4582640 (1986-04-01), Smestad et al.
patent: 4776173 (1988-10-01), Kamarei et al.
patent: 4902508 (1990-02-01), Badylak et al.
patent: 4969912 (1990-11-01), Kelman et al.
patent: 5104957 (1992-04-01), Kelman et al.
patent: 5131850 (1992-07-01), Brockbank
patent: 5160313 (1992-11-01), Carpenter et al.
patent: 5256140 (1993-10-01), Fallick
patent: 5275826 (1994-01-01), Badylak et al.
patent: 5332802 (1994-07-01), Kelman et al.
patent: 5332804 (1994-07-01), Florkiewicz et al.
patent: 5489304 (1996-02-01), Orgill et al.
patent: 5613982 (1997-03-01), Goldstein
patent: 5632778 (1997-05-01), Goldstein
patent: 5648330 (1997-07-01), Pierschbacher et al.
patent: 5695998 (1997-12-01), Badylak et al.
patent: 5712252 (1998-01-01), Smith
patent: 5728752 (1998-03-01), Scopelianos et al.
patent: 5739176 (1998-04-01), Dunn et al.
patent: 5800537 (1998-09-01), Bell
patent: 5893888 (1999-04-01), Bell
patent: 6027743 (2000-02-01), Khouri et al.
patent: 6096347 (2000-08-01), Geddes et al.
patent: 1336812 (1989-02-01), None
patent: 1336812 (1995-08-01), None
patent: 1552286 (1967-02-01), None
patent: 2104349 (1972-04-01), None
patent: 2236539 (1975-07-01), None
patent: WO84/04880 (1984-12-01), None
patent: WO93/05665 (1993-04-01), None
patent: WO93/05665 (1993-06-01), None
patent: WO 99/65470 (1999-12-01), None
Brendel et al. (1980) “Vascular Basement Membranes: Preparation and Properties of Material Isolated with the use of Detergents”The Cerebral Microvasculatureeds. Eisenberg and Suddith.
Duhamel et al. (1981) “Morphology of Bovine Cerebral and Retinal Microvascular Basement Membranes and Electrophoretic Characterization of Differential Extracts”, 11thEurope Conf. Microcirculation, Garmisch-Partenkirchen, Bibliotheca Anatomica, No. 20, pp. 134-137.
Johnson et al., (1982) “Preparation of Cell-Free Extracellular Matrix from Human Peripheral Nerve”, Muscle &Nerve 5:335-344.
Ohno et al., (1980) “Human placental chorionic villar extracellular matrix. 2. Solubilization and characterization from villar fragments fractionated according to their size”, Biological Res. In Pregnancy, 1(2):79-89.
Reichert-Jung Cryofract® 190 Cryoblock “A complete line for Freezing and Fracturing” Brochure.
“Freeze-Thaw Damage of Saccharomyces-Cerevisiae in Aqueous Cell Suspensions,” by K. Hayakawa, Hakkokogaku Kaishi 63 (1), 1985, 17-22.
Hayakawa, K., Freeze-Thaw Damage of Saccharomyces-Cerevisiae in Aqueous Cell Suspensions,Hakkokogaku Kaishi, vol. 63, No. 1, pp. 17-22.
Ohno et al., (1980) “Human placental chorionic villar extracellular matrix. 1. Preparation and chemical composition from villar fragments fractionated according to their size”, Int. J. Biol. Res. In. Pregnancy, 1(1): 38-47.
Boerboom Lawrence E.
Griffey Edward S.
Livesey Stephen A.
Schiff Charles M.
Fish & Richardson P.C.
LifeCell Coporation
Szekely Peter
LandOfFree
Particulate acellular tissue matrix does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Particulate acellular tissue matrix, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Particulate acellular tissue matrix will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3463868